http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107669626-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd37b53f7a639daf413b490204ba4613
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
filingDate 2017-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6fd7e90b6804712c8dbea8e2b8b46e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35e9d21ef2fadf5e9d81d8abd5813a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91cc2c0034cc9027c0a3eeb96558bf22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82291e4dced97d21908939cee7aae68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55a1b50061dcf1b322332d9186a67daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e87a02fdca5963a18b156169c27be9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81c1e52cddcc3d49c1580be6285db4a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53bf00607081f547ab3aed0d6fb1c507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae62d552b7f2e99755dbaaa9b886550
publicationDate 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107669626-A
titleOfInvention Preparation method and application of a high-loaded reduction-sensitive drug delivery system
abstract The invention discloses a preparation method and application of a reduction-sensitive drug delivery system with high drug loading, and belongs to the technical field of biomedicine and nanomedicine. The key points of the technical scheme of the present invention are: 2,2-dihydroxyethyl disulfide is bonded to camptothecin through a carbonate bond to construct a reduction-sensitive camptothecin dimer, and then the camptothecin The dimer is encapsulated into the amphiphilic block copolymer polyethylene glycol-polycaprolactone to obtain a high-loading reduction-sensitive drug delivery system, wherein the structural formula of the camptothecin dimer is: The invention also specifically discloses the application of the reduction-sensitive drug delivery system with high drug loading in the preparation of slow-release and targeted anticancer drugs. Compared with the camptothecin delivery system, the drug delivery system of the present invention has its drug loading increased from 1% to 12.6%, and the drug delivery system has reduction sensitivity, good biocompatibility and the ability to inhibit tumor cell proliferation. ability.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109293683-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111053911-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112656950-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112891556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112656950-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022190626-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114163458-A
priorityDate 2017-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013266508-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467647353

Total number of triples: 36.